Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00985738 · ClinicalTrials.gov registry record · Phase 2
Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer
A Phase 2 study, sponsored by University of Colorado, Denver.
- Terminated
- Registry status
- Phase 2
- Development phase
- 16
- Enrollment target
NCT00985738 is a Phase 2 study that was terminated before completion, run by University of Colorado, Denver. The registered enrollment target is 16 participants.
The verdict
NCT00985738, a Phase 2 study, was terminated before completion, sponsored by University of Colorado, Denver.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of short-term intake of daily Dutasteride in patients with prostate cancer.
Interventions
- OTHER Placebo
- DRUG Dutasteride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-09 |
| Est. Completion | 2013-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00985738
The ClinicalTrials.gov registry entry for NCT00985738 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00985738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00985738 about?
NCT00985738 is a clinical study titled "Role of Dutasteride in Patients Undergoing 3D Mapping Biopsy in Early Stage Prostate Cancer". The purpose of this study is to determine the effect of short-term intake of daily Dutasteride in patients with prostate cancer.
What is the current status of trial NCT00985738?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 16 participants. The study started on 2009-09. Estimated completion is 2013-01.
What interventions are being tested in trial NCT00985738?
The interventions under investigation include: Placebo (OTHER), Dutasteride (DRUG).
Who is sponsoring clinical trial NCT00985738?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.